Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
Developing a medical device in weeks rather than years during the coronavirus pandemic was an extraordinary undertaking. Dan Strange reviews TTP’s “Project Jarre” and draws some lessons as to how – when needs must – faster medical device development is possible.
From smiley faces to diagnostic sensors, the possibility of using DNA as a nanofabrication material is gaining increasing attention. Gary Skinner explains “DNA Origami,” its applications and what is holding back its wider adoption into the marketplace.
Many companies face important early-stage decisions about how best to access cleanroom and laboratory facilities, equipment and know-how towards microfabrication – get these decisions wrong and progress to market can become painfully slow, says Fred Hussain.
After the LeoSat and OneWeb bankruptcies and Intelsat’s Chapter 11 filing, what’s next for satcom investors? Will the 5G IoT opportunity come into sharper focus? Adrian Hillier and Peter Kibutu revisit their triangle of competitive differentiation in the satcom industry.
Agreement to harness TTP’s industry expertise to assess the potential of emerging healthcare technologies and academic research.
TTP was asked by the UK Government to assist in the rapid development and manufacture of ventilators to address the anticipated rise in demand during the Covid-19 pandemic.
TTP plc (TTP), a leading independent technology and product development company, has announced today that it has partnered with ODx (ODx Innovations Ltd), a company committed to developing a system for assessing urinary tract infections (UTIs). The collaboration is focussed on bringing ODx’ system to market through TTP’s Desktop Biology service.
TTP is working in partnership with Dyson on a new ventilator, CoVent, which aims to increase the number of ventilators available to the NHS. This work is part of a wider initiative that includes other, novel ventilator designs that are being pursued in parallel. These ventilators are urgently needed for treating COVID-19 patients suffering with Acute Respiratory Distress Syndrome (ARDS).
